GLP-1 news & analysis

Analysis: best wegovy alternatives in 2026 (by cost, effectiveness, insurance)

Analysis: does zepbound cause hair loss? what the data shows (2026)

Analysis: how to get mounjaro for $25 a month (2026 savings card guide)

Analysis: why compounded glp-1 is so much cheaper (and when that's a red flag)

Analysis: legitscript certification, explained for glp-1 patients

Analysis: 503a vs 503b pharmacies: what patients actually need to know

Analysis: novo sues hims, then drops it: the story behind the hims-novo partnership

Analysis: fda compounding rules after the semaglutide shortage ended

Analysis: orforglipron (foundayo) explained: the first oral glp-1 for obesity

Analysis: is oral glp-1 ready to replace injections?

Analysis: glp-1 and alcohol use: what the emerging data shows

Analysis: glp-1 and fertility: conception, washout, and postpartum

Analysis: glp-1 for pcos: off-label use and the evidence base

Analysis: glp-1 and mental health: depression, suicidality, and what fda found

Analysis: glp-1 and bone density: what long-term data shows

Analysis: glp-1 shortages update (may 2026)

Analysis: research peptides vs glp-1: the critical difference

Analysis: tirzepatide vs retatrutide: what the pipeline looks like

Analysis: glp-1 cardiovascular outcomes: select, step-hfpef, and surmount-cv

Analysis: glp-1 and kidney function: the flow trial and beyond

Analysis: glp-1 for mash and fatty liver: where the evidence is

Analysis: why weight comes back after stopping glp-1 — and how to prevent it

Analysis: real patient outcomes on glp-1: what 50 stories show

Analysis: glp-1 in 2025: the year in review

Analysis: wegovy vs ozempic: they're literally the same drug — here's why prices differ

Analysis: glp-1 pricing around the world

Analysis: medicare glp-1 bridge: how to cover the gap before july 2026

Analysis: the compounded pharmacy list every glp-1 patient should know

Analysis: the most important glp-1 research of 2026 (so far)

Analysis: how the glp-1 market is reshaping healthcare stocks